<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="dmtn" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">dmtn</book-part-id>
      <title-group>
        <title>Diabetes Mellitus, 6q24-Related Transient Neonatal</title>
        <alt-title alt-title-type="alt-title">Synonym: 6q24-TNDM</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Temple</surname>
            <given-names>Isabel Karen</given-names>
          </name>
          <degrees>MD, MBChB, FRCP</degrees>
          <aff>Professor of Medical Genetics, Human Genetics and Genomic Medicine<break/>Academic Unit of Human Development and Health<break/>Faculty of Medicine, University of Southampton<break/>Honorary Consultant in Clinical Genetics, Wessex Clinical Genetics Service<break/>Southampton University Hospitals NHS Trust<break/>Southampton, Hampshire, United Kingdom</aff>
          <email>ikt@southampton.ac.uk</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Mackay</surname>
            <given-names>Deborah JG</given-names>
          </name>
          <degrees>PhD, MA</degrees>
          <aff>Reader of Medical Epigenetics, Epigenetics<break/>Academic Unit of Human Development and Health<break/>Faculty of Medicine, University of Southampton<break/>Wessex Regional Genetics Laboratory<break/>Salisbury NHS Foundation Trust<break/>Salisbury, United Kingdom</aff>
          <email>djgm@southampton.ac.uk</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Docherty</surname>
            <given-names>Louise Esther</given-names>
          </name>
          <degrees>PhD, BSc (hons)</degrees>
          <aff>Post-Doctoral Research Fellow, Epigenetics<break/>Academic Unit of Human Development and Health<break/>Faculty of Medicine, University of Southampton<break/>Wessex Regional Genetics Laboratory<break/>Salisbury NHS Foundation Trust<break/>Salisbury, United Kingdom</aff>
          <email>l.e.docherty@soton.ac.uk</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date iso-8601-date="2005-10-10" date-type="created">
          <day>10</day>
          <month>10</month>
          <year>2005</year>
        </date>
        <date iso-8601-date="2015-01-15" date-type="updated">
          <day>15</day>
          <month>1</month>
          <year>2015</year>
        </date>
        <date iso-8601-date="2010-12-23" date-type="revised">
          <day>23</day>
          <month>12</month>
          <year>2010</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="dguok-mtddepl" document-type="chapter">Deoxyguanosine Kinase Deficiency</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="diamond-b" document-type="chapter">Diamond-Blackfan Anemia</related-object>
      <abstract id="dmtn.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>6q24-related transient neonatal diabetes mellitus (6q24-TNDM) is defined as transient neonatal diabetes mellitus caused by genetic aberrations of the imprinted locus at 6q24. The cardinal features are: severe intrauterine growth retardation, hyperglycemia that begins in the neonatal period in a term infant and resolves by age 18 months, dehydration, and absence of ketoacidosis. Macroglossia and umbilical hernia are often present. In the subset of children with <italic toggle="yes">ZFP57</italic> pathogenic variants, other manifestations can include structural brain abnormalities, developmental delay, and congenital heart disease. Diabetes mellitus usually starts within the first week of life and lasts on average three months but can last longer than a year. Although insulin is usually required initially, the need for insulin gradually declines over time. Intermittent episodes of hyperglycemia may occur in childhood, particularly during intercurrent illnesses. Diabetes mellitus may recur in adolescence or later in adulthood. Women who have had 6q24-TNDM are at risk for relapse during pregnancy.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>6q24-TNDM is caused by overexpression of the imprinted genes at 6q24 (<italic toggle="yes">PLAGL1</italic> [<italic toggle="yes">ZAC</italic>] and <italic toggle="yes">HYMAI</italic>). A &#x02018;differentially methylated region&#x02019; (DMR) is present within the shared promoter of these genes. Normally, expression of the maternal alleles of <italic toggle="yes">PLAGL1</italic> and <italic toggle="yes">HYMAI</italic> are silenced by DMRmethylation and only the paternal alleles of <italic toggle="yes">PLAGL1</italic> and <italic toggle="yes">HYMAI</italic> are expressed. Three different genetic mechanisms result in twice the normal dosage of these two genes and cause 6q24-TNDM:</p>
          <list list-type="bullet">
            <list-item>
              <p>Paternal uniparental disomy of chromosome 6 (41%);</p>
            </list-item>
            <list-item>
              <p>Duplication of 6q24 on the paternal allele (29%); and</p>
            </list-item>
            <list-item>
              <p>Hypomethylation of the maternal DMR resulting in inappropriate expression of the maternal <italic toggle="yes">PLAGL1</italic> and <italic toggle="yes">HYMAI</italic> alleles (30%).</p>
            </list-item>
          </list>
          <p>Maternal <italic toggle="yes">PLAGL1/HYMAI</italic> DMR hypomethylation may result from an isolated imprinting variant or as part of a more generalized defect termed &#x02018;hypomethylation at imprinted loci&#x02019; (HIL). Homozygous or compound heterozygous <italic toggle="yes">ZFP57</italic> pathogenic variants account for almost half of TNDM-HIL; the other causes of HIL are not known. Rapid testing can confirm the diagnosis of 6q24-TNDM by detecting methylation changes resulting from any of the three mechanisms of disease causation. Additional clinical testing can detect paternal UPD6 and paternal 6q24 duplication.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> Rehydration and IV insulin are usually required at the time of diagnosis; subcutaneous insulin is introduced as soon as possible and used until blood glucose levels stabilize. Later recurrence of diabetes may require diet alone, oral agents, or insulin.</p>
          <p><italic toggle="yes">Prevention of secondary complications:</italic> Prompt treatment of dehydration to avoid sequelae.</p>
          <p><italic toggle="yes">Surveillance:</italic> Periodic glucose tolerance tests; abnormalities suggest future recurrence.</p>
          <p><italic toggle="yes">Evaluation of relatives at risk:</italic> Screening for diabetes mellitus in relatives who have inherited a paternal 6q24 duplication or who are at risk of having inherited two <italic toggle="yes">ZFP57</italic> pathogenic variants.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>The risk to sibs and offspring of a proband of having 6q24-TNDM or of developing diabetes later in life depends on the genetic mechanism in the family. Recurrence risk counseling by a genetics professional is strongly recommended. 6q24-TNDM caused by paternal UPD6 is typically a <italic toggle="yes">de novo</italic>, non-recurrent event. 6q24-TNDM caused by paternal dup6q24 can occur <italic toggle="yes">de novo</italic>, be inherited in an autosomal dominant manner, or be inherited as a part of a complex chromosome rearrangement; TNDM caused by an inherited dup6q24 may recur in sibs and offspring of a proband if the duplication is inherited from the father. Prenatal diagnosis of paternal dup6q24 is possible in pregnancies at risk for a structural chromosome abnormality. TNDM-HIL is inherited in an autosomal recessive manner when caused by pathogenic variants in <italic toggle="yes">ZFP57</italic>; however, the phenotype of homozygous or compound heterozygous sibs is variable and cannot be predicted by molecular genetic testing.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="dmtn.Diagnosis">
        <title>Diagnosis</title>
        <sec id="dmtn.Suggestive_Findings">
          <title>Suggestive Findings</title>
          <p>Diagnosis of 6q24-related transient neonatal diabetes mellitus (6q24-TNDM) should be suspected in individuals with the following clinical features:</p>
          <list list-type="bullet">
            <list-item>
              <p>Severe intrauterine growth restriction</p>
            </list-item>
            <list-item>
              <p>Diabetes mellitus that commences in the first six weeks of life in a term infant and resolves by age 18 months. Presentation includes:</p>
              <list list-type="bullet">
                <list-item>
                  <p>Hyperglycemia</p>
                </list-item>
                <list-item>
                  <p>Dehydration</p>
                </list-item>
                <list-item>
                  <p>Plasma insulin concentrations that are low in the presence of high serum glucose concentrations</p>
                </list-item>
                <list-item>
                  <p>Absence of ketoacidosis.Ketones are usually not present in the urine.</p>
                </list-item>
                <list-item>
                  <p>Absence of islet cell antibodies</p>
                </list-item>
              </list>
            </list-item>
          </list>
        </sec>
        <sec id="dmtn.Establishing_the_Diagnosis">
          <title>Establishing the Diagnosis</title>
          <p>The diagnosis of 6q24-TNDM is established in a proband with identification of hypomethylation within the 6q24 &#x02018;differentially methylated region&#x02019; (DMR).</p>
          <p>DNA methylation analysis is the only technique that will diagnose 6q24-TNDM caused by all three genetic mechanisms (partial or complete paternal uniparental disomy of chromosome 6, paternal duplication of 6q24, and hypomethylation of the maternal <italic toggle="yes">PLAGL1</italic> and <italic toggle="yes">HYMAI</italic> DMR). Note: While hypomethylation within the 6q24 DMR is sufficient for clinical diagnosis, it is not sufficient to determine the underlying genetic mechanism, which is required for accurate <xref ref-type="sec" rid="dmtn.Genetic_Counseling">genetic counseling</xref>.</p>
          <p>Normally, expression of the maternal alleles of <italic toggle="yes">PLAGL1</italic> and <italic toggle="yes">HYMAI</italic> are silenced by DMR methylation and only the paternal alleles of <italic toggle="yes">PLAGL1</italic> and <italic toggle="yes">HYMAI</italic> are expressed. In 6q24-TNDM, <italic toggle="yes">PLAGL1</italic> and <italic toggle="yes">HYMAI</italic> alleles are overexpressed through one of the three following genetic mechanisms (see <xref ref-type="fig" rid="dmtn.F1">Figure 1</xref>):</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Partial or complete paternal uniparental disomy of chromosome 6 (UPD6).</bold> Two chromosome 6q24 regions, each with an expressed copy of <italic toggle="yes">PLAGL1</italic> and <italic toggle="yes">HYMAI</italic>, are inherited from the father and none are inherited from the mother.</p>
            </list-item>
            <list-item>
              <p><bold>Paternal duplication of 6q24.</bold> Usually a submicroscopic duplication results in the presence of two copies of <italic toggle="yes">PLAGL1</italic> and <italic toggle="yes">HYMAI</italic> on one paternal chromosome 6.</p>
            </list-item>
            <list-item>
              <p><bold>Hypomethylation of the maternal <italic toggle="yes">PLAGL1</italic> and <italic toggle="yes">HYMAI</italic> DMR.</bold> This can result from either an isolated imprinting mutation of the DMR or as part of a more generalized &#x02018;hypomethylation at imprinted loci&#x02019; (HIL), caused by biallelic (homozygous or compound heterozygous) pathogenic variants in <italic toggle="yes">ZFP57</italic> or as-yet unknown mechanisms.</p>
            </list-item>
          </list>
        </sec>
        <sec id="dmtn.Testing_Strategy">
          <title>Testing Strategy</title>
          <p><bold>Tier 1</bold>
<bold>testing</bold> (ratiometric methylated/unmethylated DNA measurement) detects hypomethylation within the 6q24 DMR region regardless of the underlying genetic mechanism, thus establishing the diagnosis of 6q24-related TNDM.</p>
          <p><bold>Tier 2 testing</bold> is necessary to differentiate the two different genetic mechanisms that cause an extra copy of the paternal DMR region (see <xref ref-type="table" rid="dmtn.T.summary_of_molecular_genetic_test">Table 1</xref>).</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Uniparental disomy (UPD) studies</bold> are used to detect paternal UPD6.</p>
            </list-item>
            <list-item>
              <p><bold>Duplication of 6q24.</bold> A variety of methods may be used for deletion/duplication analysis (copy number analysis) to identify an additional paternal copy of <italic toggle="yes">PLAGL1/HYMAI</italic> (see <xref ref-type="table" rid="dmtn.T.summary_of_molecular_genetic_test">Table 1</xref>, footnote 3).</p>
            </list-item>
          </list>
          <p><bold>Tier 3 testing.</bold> To determine the cause of hypomethylation of the maternal <italic toggle="yes">PLAGL1/HYMAI</italic> differentially methylated region (DMR) in the absence of paternal UPD6 or 6q24 duplication, molecular genetic testing of <italic toggle="yes">ZFP57</italic> can be considered.</p>
          <table-wrap id="dmtn.T.summary_of_molecular_genetic_test" position="anchor" orientation="portrait">
            <label>Table 1. </label>
            <caption>
              <p>Summary of Molecular Genetic Testing Used in 6q24-Related Transient Neonatal Diabetes Mellitus</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_dmtn.T.summary_of_molecular_genetic_test_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Tiered Testing Strategy&#x000a0;<sup>1</sup></th>
                  <th id="hd_h_dmtn.T.summary_of_molecular_genetic_test_1_1_1_2" valign="middle" colspan="2" align="left" scope="colgroup" rowspan="1">Genetic Mechanisms Detected</th>
                  <th id="hd_h_dmtn.T.summary_of_molecular_genetic_test_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Test Method</th>
                  <th id="hd_h_dmtn.T.summary_of_molecular_genetic_test_1_1_1_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">% of All 6q24-Related TNDM Identified</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_dmtn.T.summary_of_molecular_genetic_test_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Tier 1</td>
                  <td headers="hd_h_dmtn.T.summary_of_molecular_genetic_test_1_1_1_2" valign="middle" colspan="2" align="left" rowspan="1">All</td>
                  <td headers="hd_h_dmtn.T.summary_of_molecular_genetic_test_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Ratiometric methylated/unmethylated DNA analysis&#x000a0;<sup>2</sup></td>
                  <td headers="hd_h_dmtn.T.summary_of_molecular_genetic_test_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">100%</td>
                </tr>
                <tr>
                  <td headers="hd_h_dmtn.T.summary_of_molecular_genetic_test_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">Tier 2</td>
                  <td headers="hd_h_dmtn.T.summary_of_molecular_genetic_test_1_1_1_2" valign="middle" colspan="2" align="left" rowspan="1">Uniparental disomy 6</td>
                  <td headers="hd_h_dmtn.T.summary_of_molecular_genetic_test_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Uniparental disomy studies&#x000a0;<sup>3</sup></td>
                  <td headers="hd_h_dmtn.T.summary_of_molecular_genetic_test_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">~41%</td>
                </tr>
                <tr>
                  <td headers="hd_h_dmtn.T.summary_of_molecular_genetic_test_1_1_1_2" valign="middle" colspan="2" align="left" scope="row" rowspan="1">Duplication of 6q24</td>
                  <td headers="hd_h_dmtn.T.summary_of_molecular_genetic_test_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Deletion/duplication analysis&#x000a0;<sup>4,&#x000a0;5</sup></td>
                  <td headers="hd_h_dmtn.T.summary_of_molecular_genetic_test_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">~29%</td>
                </tr>
                <tr>
                  <td headers="hd_h_dmtn.T.summary_of_molecular_genetic_test_1_1_1_1" rowspan="3" valign="middle" align="left" scope="row" colspan="1">Tier 3</td>
                  <td headers="hd_h_dmtn.T.summary_of_molecular_genetic_test_1_1_1_2" rowspan="3" valign="middle" align="left" colspan="1">Hypomethylation of maternal DMR with normal Tier 2 testing</td>
                  <td headers="hd_h_dmtn.T.summary_of_molecular_genetic_test_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Mutation of <italic toggle="yes">ZFP57</italic>&#x000a0;<sup>6</sup></td>
                  <td headers="hd_h_dmtn.T.summary_of_molecular_genetic_test_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>7</sup></td>
                  <td headers="hd_h_dmtn.T.summary_of_molecular_genetic_test_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">9%&#x000a0;<sup>8</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_dmtn.T.summary_of_molecular_genetic_test_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Isolated imprinting center mutation&#x000a0;<sup>9</sup></td>
                  <td headers="hd_h_dmtn.T.summary_of_molecular_genetic_test_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">(By exclusion of other causes) No additional imprinting errors detected</td>
                  <td headers="hd_h_dmtn.T.summary_of_molecular_genetic_test_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">10%</td>
                </tr>
                <tr>
                  <td headers="hd_h_dmtn.T.summary_of_molecular_genetic_test_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">As part of HIL but cause unknown</td>
                  <td headers="hd_h_dmtn.T.summary_of_molecular_genetic_test_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">NA</td>
                  <td headers="hd_h_dmtn.T.summary_of_molecular_genetic_test_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">11%</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="dmtn.TF.1.1">
                <label>1. </label>
                <p>See <xref ref-type="sec" rid="dmtn.Testing_Strategy">Testing Strategy</xref>.</p>
              </fn>
              <fn id="dmtn.TF.1.2">
                <label>2. </label>
                <p>Ratio of methylated to unmethylated DNA within the differentially methylated region (DMR) [<xref ref-type="bibr" rid="dmtn.REF.mackay.2005.255">Mackay et al 2005</xref>]. Methylation-specific PCR (MSPCR) of bisulfited DNA produces amplicons representing the unmethylated and methylated alleles, the amounts of which are represented on an electropherogram as peak heights. The presence of an equivalent abundance of methylated and unmethylated DNA is consistent with a normal 1:1 unmethylated/methylated ratio. The patient&#x02019;s ratio is compared to that of at least four normal controls in the same experiment. Hypomethylation (i.e., greater peak intensity for the unmethylated than the methylated amplicon of &#x0003e;3 SD greater than normal) is indicative of a positive result.</p>
              </fn>
              <fn id="dmtn.TF.1.3">
                <label>3. </label>
                <p>Testing used to identify if specific chromosomes or chromosomal segments are maternally or paternally derived</p>
              </fn>
              <fn id="dmtn.TF.1.4">
                <label>4. </label>
                <p>Testing that identifies deletions/duplications not readily detectable by sequence analysis of the coding and flanking intronic regions of genomic DNA; included in the variety of methods that may be used are: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and chromosomal microarray (CMA) that includes this gene/chromosome segment.</p>
              </fn>
              <fn id="dmtn.TF.1.5">
                <label>5. </label>
                <p>A small minority of individuals have a cytogenetically visible duplication of 6q24 [<xref ref-type="bibr" rid="dmtn.REF.temple.1996.1117">Temple et al 1996</xref>, <xref ref-type="bibr" rid="dmtn.REF.arthur.1997.417">Arthur et al 1997</xref>]. If paternal 6q24 duplication is identified, conventional karyotype analysis is performed to determine if visible chromosome translocations or insertions are causative.</p>
              </fn>
              <fn id="dmtn.TF.1.6">
                <label>6. </label>
                <p>See <related-object source-id="gene" document-id="dmtn" object-id="dmtn.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein name. See <xref ref-type="sec" rid="dmtn.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants detected in this gene.</p>
              </fn>
              <fn id="dmtn.TF.1.7">
                <label>7. </label>
                <p>Sequence analysis detects variants that are benign, likely benign, of unknown significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
              </fn>
              <fn id="dmtn.TF.1.8">
                <label>8. </label>
                <p>
                  <xref ref-type="bibr" rid="dmtn.REF.docherty.2013.758">Docherty et al [2013]</xref>
                </p>
              </fn>
              <fn id="dmtn.TF.1.9">
                <label>9. </label>
                <p>Diagnosis of exclusion</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p><bold>Test characteristics.</bold> See <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.nature.com/ejhg/journal/v22/n9/full/ejhg201427a.html">Clinical Utility Gene Card</ext-link> [<xref ref-type="bibr" rid="dmtn.REF.mackay.2014">Mackay et al 2014</xref>] for information on test characteristics including sensitivity and specificity.</p>
        </sec>
      </sec>
      <sec id="dmtn.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="dmtn.Clinical_Description">
          <title>Clinical Description</title>
          <p>Females and males are equally likely to be affected.</p>
          <p><bold>Pregnancy.</bold> Growth retardation may be noted in the third trimester.</p>
          <p><bold>In the neonate.</bold> Intrauterine growth retardation is a key feature; the mean birth weight in a study of 30 infants was 1930 g at 39 weeks' gestation [<xref ref-type="bibr" rid="dmtn.REF.temple.2000.1359">Temple et al 2000</xref>]. This is in keeping with other studies [<xref ref-type="bibr" rid="dmtn.REF.metz.2002.483">Metz et al 2002</xref>, <xref ref-type="bibr" rid="dmtn.REF.diatloffzito.2007.31">Diatloff-Zito et al 2007</xref>]. Because the plasma concentration of insulin is low at the time of diagnosis, it is assumed that low birth weight is a result of low in utero levels of insulin, an important prenatal growth factor.</p>
          <p>Diabetes mellitus tends to develop in the first week of life, although it may not be recognized until later. Hyperglycemia may be identified by chance during routine investigations in the newborn period for a sick dehydrated infant. Infants rapidly become dehydrated and usually require insulin. The diabetes may be resistant to treatment initially. Occasionally insulin is not required and neonates are treated with rehydration alone.</p>
          <p>Macroglossia and umbilical hernia are sometimes observed. No other dysmorphic features are consistently associated with this condition. Screening for congenital hypothyroidism is prudent.</p>
          <p>6q24-TNDM caused by generalized HIL (hypomethylation at imprinted loci) can be associated with marked hypotonia, congenital heart disease, deafness, neurologic features including epilepsy, and renal malformations.</p>
          <p><bold>In infancy.</bold> Diabetes mellitus lasts on average three months but has been reported to last longer than a year [<xref ref-type="bibr" rid="dmtn.REF.temple.2000.1359">Temple et al 2000</xref>]. The need for insulin gradually declines. This is often accompanied by a significant weight gain and catch-up growth and some infants become overweight in the first year [<xref ref-type="bibr" rid="dmtn.REF.metz.2002.483">Metz et al 2002</xref>].</p>
          <p><bold>In childhood.</bold> Intermittent episodes of hyperglycemia may occur in childhood, particularly during intercurrent illnesses. Few studies have been performed during this period and so the extent of these episodes is not known. <xref ref-type="bibr" rid="dmtn.REF.shield.2004.f341">Shield et al [2004]</xref> studied seven children during this period and found low insulin secretion in four and normal insulin secretion in three.</p>
          <p>Diabetes may recur in very early childhood.</p>
          <p>Permanent diabetes mellitus can occur in up to 50% in some series [<xref ref-type="bibr" rid="dmtn.REF.temple.2000.1359">Temple et al 2000</xref>], although this figure may overestimate the actual risk because of the bias of identifying affected individuals. There is usually some residual endogenous insulin production; however, insulin therapy may be needed.</p>
          <p><bold>In adolescence.</bold> The average age of recurrence in the series of <xref ref-type="bibr" rid="dmtn.REF.temple.2000.1359">Temple et al [2000]</xref> was 14 years, coinciding with puberty. Some individuals require insulin; others are treated with oral drugs or diet alone. In a series from France, five of seven individuals developed diabetes again after age eight years [<xref ref-type="bibr" rid="dmtn.REF.metz.2002.483">Metz et al 2002</xref>].</p>
          <p>Intelligence and growth are usually normal in this condition except in individuals with loss of methylation at multiple loci, who may have developmental delay.</p>
          <p><bold>In adulthood.</bold> Women are at risk for relapse during pregnancy and may present with gestational diabetes mellitus.</p>
          <p>Studies have not been performed to assess the level of diabetes-related complications that can occur in this disorder. One individual with poor compliance with treatment had persistent hyperglycemia from ages 14 to 28 years. He did not develop ketoacidosis but did develop evidence of microangiopathy [<xref ref-type="bibr" rid="dmtn.REF.valerio.2004.2405">Valerio et al 2004</xref>].</p>
        </sec>
        <sec id="dmtn.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p><bold>Diabetes mellitus.</bold> No difference in the severity, duration, or relapse rate of diabetes has been detected between the 6q24-TNDM etiologic subgroups [<xref ref-type="bibr" rid="dmtn.REF.temple.2000.1359">Temple et al 2000</xref>].</p>
          <p>Non-diabetes manifestations vary by causative genetic mechanism:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>UPD6.</bold> The majority of UPD6 is isodisomic, i.e., two copies of chromosome 6 are identical and therefore the affected individual is at increased risk for rare autosomal recessive disorders that may be unmasked by this unusual inheritance pattern. The most common is <related-object link-type="booklink" source-id="gene" document-id="hemochromatosis" document-type="chapter"><italic toggle="yes">HFE</italic>-associated hereditary hemochromatosis</related-object>, for which testing can be performed in adulthood. <related-object link-type="booklink" source-id="gene" document-id="mma" document-type="chapter">Methylmalonic acidemia</related-object> and congenital adrenal hyperplasia caused by <related-object link-type="booklink" source-id="gene" document-id="cah" document-type="chapter">21-hydroxylase deficiency</related-object> have also been described as occurring through this mechanism.</p>
            </list-item>
            <list-item>
              <p><bold>6q duplication.</bold> Cytogenetically visible duplication of 6q can also be associated with learning difficulties related to other genes within the duplicated region. Note: Individuals with a submicroscopic 6q24 duplication are usually of normal intelligence.</p>
            </list-item>
            <list-item>
              <p><bold>Hypomethylation of the maternal <italic toggle="yes">PLAGL1/HYMAI</italic> DMR.</bold> Non-diabetes manifestations are more likely in the subgroup with generalized hypomethylation at imprinted loci (HIL) and can include significant learning difficulties [<xref ref-type="bibr" rid="dmtn.REF.boonen.2008.453">Boonen et al 2008</xref>, <xref ref-type="bibr" rid="dmtn.REF.mackay.2008.949">Mackay et al 2008</xref>]. No correlation has been observed between clinical severity and either the degree of hypomethylation or the range of loci involved. For example, the features seen in individuals with 6q24-TNDM caused by homozygous or compound heterozygous <italic toggle="yes">ZFP57</italic> pathogenic variants can vary from severe intellectual disability and early infant death to a normal phenotype. It is therefore difficult to predict the phenotype in individuals with HIL, possibly because of the inability to interrogate all imprinted loci.</p>
            </list-item>
          </list>
        </sec>
        <sec id="dmtn.Penetrance">
          <title>Penetrance</title>
          <p>Reduced penetrance of the 6q24-TNDM phenotype is rare but has been noted when siblings of affected individuals were found to have an identical paternal duplication of 6q24 but no history of neonatal diabetes mellitus [<xref ref-type="bibr" rid="dmtn.REF.valerio.2004.2405">Valerio et al 2004</xref>].</p>
          <p>Reduced penetrance has also been shown in an individual homozygous for <italic toggle="yes">ZFP57</italic> pathogenic variants.</p>
        </sec>
        <sec id="dmtn.Anticipation">
          <title>Anticipation</title>
          <p>Anticipation has not been noted.</p>
        </sec>
        <sec id="dmtn.Prevalence">
          <title>Prevalence</title>
          <p>Prevalence of TNDM in the UK was initially estimated at 1:400,000 as reported by <xref ref-type="bibr" rid="dmtn.REF.shield.1997.f39">Shield et al [1997]</xref>. More recent calculations confirm a total neonatal diabetes incidence of 1:215,000 to 1:400,000 [<xref ref-type="bibr" rid="dmtn.REF.polak.2004.59">Polak &#x00026; Shield 2004</xref>, <xref ref-type="bibr" rid="dmtn.REF.stanik.2007.1276">Stanik et al 2007</xref>, <xref ref-type="bibr" rid="dmtn.REF.wiedemann.2010.18">Wiedemann et al 2010</xref>]. Fifty percent of neonatal diabetes mellitus is transient rather than permanent (see <related-object link-type="booklink" source-id="gene" document-id="dmn" document-type="chapter">Permanent Neonatal Diabetes Mellitus</related-object>).</p>
        </sec>
      </sec>
      <sec id="dmtn.Genetically_Related_Allelic_Disorde">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>No phenotypes other than those discussed in this <italic toggle="yes">GeneReview</italic> are known to be associated with overexpression of <italic toggle="yes">PLAGL1</italic> (<italic toggle="yes">ZAC</italic>) and <italic toggle="yes">HYMAI</italic>.</p>
      </sec>
      <sec id="dmtn.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Transient neonatal diabetes mellitus (TNDM) was found to account for approximately 50% of diabetes mellitus presenting in the neonatal period [<xref ref-type="bibr" rid="dmtn.REF.cav_.2000.108">Cav&#x000e9; et al 2000</xref>, <xref ref-type="bibr" rid="dmtn.REF.metz.2002.483">Metz et al 2002</xref>, <xref ref-type="bibr" rid="dmtn.REF.polak.2007.12">Polak &#x00026; Cav&#x000e9; 2007</xref>]. <xref ref-type="bibr" rid="dmtn.REF.flanagan.2007.1930">Flanagan et al [2007]</xref> showed that 70% of TNDM was caused by 6q24 aberrations. Other genetic causes of transient neonatal diabetes mellitus include pathogenic variants in <italic toggle="yes">KCNJ11</italic> and <italic toggle="yes">ABCC8,</italic> which usually cause permanent neonatal diabetes (see also <related-object link-type="booklink" source-id="gene" document-id="dmn" document-type="chapter">Permanent Neonatal Diabetes Mellitus</related-object>).</p>
        <p><xref ref-type="bibr" rid="dmtn.REF.metz.2002.483">Metz et al [2002]</xref> failed to demonstrate clear clinical indicators to differentiate 6q24-TNDM from other causes in a large cohort of 50 individuals presenting with neonatal diabetes.</p>
        <p>Other genetic causes of neonatal diabetes mellitus (isolated and syndromic, transient and permanent):</p>
        <list list-type="bullet">
          <list-item>
            <p><bold><italic toggle="yes">KCNJ11</italic>- and <italic toggle="yes">ABCC8</italic></bold><italic toggle="yes">-</italic><bold>related neonatal diabetes mellitus.</bold> Pathogenic variants in <italic toggle="yes">KCNJ11</italic> and <italic toggle="yes">ABCC8</italic> are important causes of neonatal diabetes mellitus coding for the Kir 6.2 and SUR1 subunits, respectively, of the ATP-sensitive potassium channel of pancreatic &#x003b2; cells. This KATP channel is a key regulator of insulin release, coupling cell metabolism to electrical activity through the movement of potassium across the membrane [<xref ref-type="bibr" rid="dmtn.REF.gloyn.2004.1838">Gloyn et al 2004</xref>]. Together, heterozygous pathogenic variants in these two genes account for 33%-50% of permanent neonatal diabetes [<xref ref-type="bibr" rid="dmtn.REF.gloyn.2004.1838">Gloyn et al 2004</xref>] and 26% of transient neonatal diabetes [<xref ref-type="bibr" rid="dmtn.REF.flanagan.2007.1930">Flanagan et al 2007</xref>]. Affected infants present with low birth weight and hyperglycemia. Compared to 6q24-TNDM, <italic toggle="yes">KCNJ11</italic>- and <italic toggle="yes">ABCC8-</italic>related neonatal diabetes usually present slightly later, birth weight is higher, remission usually takes longer, and ketoacidosis is often present at diagnosis. Some of the children have epilepsy, hypotonia, and developmental delay in addition to diabetes mellitus (DEND syndrome). DEND syndrome has been associated with both <italic toggle="yes">KCNJ11</italic> and <italic toggle="yes">ABCC8</italic> pathogenic variants [<xref ref-type="bibr" rid="dmtn.REF.proks.2007.2011">Proks et al 2007</xref>]. Phenotype correlates with genotype depending on the impact of the pathogenic variant on ATP binding [<xref ref-type="bibr" rid="dmtn.REF.gloyn.2005.925">Gloyn et al 2005</xref>, <xref ref-type="bibr" rid="dmtn.REF.gloyn.2006.824">Gloyn et al 2006</xref>].</p>
          </list-item>
          <list-item>
            <p><bold><italic toggle="yes">INS</italic>-related neonatal diabetes mellitus</bold>. Twenty-three percent of probands presenting with diabetes before age six months were found to have heterozygous pathogenic variants in the insulin gene, <italic toggle="yes">INS</italic> [<xref ref-type="bibr" rid="dmtn.REF.edghill.2008.1034">Edghill et al 2008</xref>]<italic toggle="yes">.</italic> This is the second most common cause of permanent neonatal diabetes, a finding supported by a national US study of early-onset diabetes [<xref ref-type="bibr" rid="dmtn.REF.st_y.2008.450">St&#x000f8;y et al 2008</xref>]. Although the median age of diagnosis was 11 weeks, the range of the age of onset overlaps with neonatal diabetes; therefore, pathogenic variants in <italic toggle="yes">INS</italic> should be considered in the differential diagnosis of 6q24-TNDM. Presentation includes ketoacidosis in half of the infants. Clinical findings can vary among family members. In at least one family in the series neonatal diabetes was transient, becoming permanent diabetes at age two years.</p>
          </list-item>
          <list-item>
            <p><bold>Glucokinase-related neonatal diabetes mellitus.</bold> Homozygous missense loss-of-function variants within <italic toggle="yes">GCK</italic>, the gene encoding glucokinase, have been reported as a rare cause of <related-object link-type="booklink" source-id="gene" document-id="dmn" document-type="chapter">permanent neonatal diabetes mellitus</related-object>, (4%). This condition should be considered, particularly in consanguineous families [<xref ref-type="bibr" rid="dmtn.REF.nj_lstad.2001.1588">Nj&#x000f8;lstad et al 2001</xref>, <xref ref-type="bibr" rid="dmtn.REF.nj_lstad.2003.2854">Nj&#x000f8;lstad et al 2003</xref>]. Glucokinase-related neonatal diabetes mellitus is inherited in an autosomal recessive manner.</p>
          </list-item>
          <list-item>
            <p><bold><italic toggle="yes">PDX1</italic> (<italic toggle="yes">IPF-1</italic>)-related neonatal diabetes mellitus.</bold>
<xref ref-type="bibr" rid="dmtn.REF.stoffers.1997.106">Stoffers et al [1997]</xref> were the first to describe <related-object link-type="booklink" source-id="gene" document-id="dmn" document-type="chapter">permanent neonatal diabetes mellitus</related-object> in a child with pancreatic agenesis who was homozygous for a single-nucleotide deletion in <italic toggle="yes">PDX1</italic>, encoding the homeodomain protein IPF-1, a critical regulator of insulin gene function in the islet cell. Imaging of the pancreas may help to differentiate such cases [<xref ref-type="bibr" rid="dmtn.REF.schwitzgebel.2003.4398">Schwitzgebel et al 2003</xref>]. This is a very rare cause of pancreatic agenesis (&#x0003c;1%). <italic toggle="yes">PDX1</italic>-related neonatal diabetes mellitus is inherited in an autosomal recessive manner.</p>
          </list-item>
          <list-item>
            <p><bold><italic toggle="yes">HNF1B</italic> pathogenic variants</bold>. Occasional cases of neonatal diabetes mellitus have been reported with heterozygous pathogenic variants in <italic toggle="yes">HNF1B</italic> [<xref ref-type="bibr" rid="dmtn.REF.yorifuji.2004.2905">Yorifuji et al 2004</xref>, <xref ref-type="bibr" rid="dmtn.REF.edghill.2006.1301">Edghill et al 2006</xref>]. The individual reported by <xref ref-type="bibr" rid="dmtn.REF.edghill.2006.1301">Edghill et al [2006]</xref> had transient neonatal diabetes mellitus with recurrence at age eight years. Pathogenic variants in this gene usually cause MODY5 (maturity-onset diabetes of the young type 5) characterized by dominantly inherited adolescent-onset diabetes mellitus associated with renal cysts.</p>
          </list-item>
          <list-item>
            <p><bold>Wolcott-Rallison syndrome</bold> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/226980">OMIM</ext-link>), caused by pathogenic variants in <italic toggle="yes">EIF2AK3</italic>, is characterized by infantile-onset (often within the neonatal period) diabetes mellitus and spondyloepiphyseal dysplasia, which may develop after the neonatal period. <italic toggle="yes">EIF2AK3</italic> is highly expressed in pancreatic islet cells, acting as a regulator of protein synthesis. Wolcott-Rallison syndrome is inherited in an autosomal recessive manner.</p>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="ipex" document-type="chapter"><bold>IPEX Syndrome</bold></related-object>
<bold>(<italic toggle="yes">i</italic>mmune dysregulation, <italic toggle="yes">p</italic>olyendocrinopathy, <italic toggle="yes">e</italic>nteropathy, <italic toggle="yes">X</italic>-linked)</bold><related-object link-type="booklink" source-id="gene" document-id="ipex" document-type="chapter"> can be caused by pathogenic variants in<italic toggle="yes"> FOXP3</italic>
</related-object>and is characterized by the development of overwhelming systemic autoimmunity in the first year of life resulting in the commonly observed triad of watery diarrhea, eczematous dermatitis, and endocrinopathy, most often insulin-dependent diabetes mellitus. Most infants have other autoimmune phenomena including Coombs-positive anemia, autoimmune thrombocytopenia, autoimmune neutropenia, and tubular nephropathy. Without aggressive immunosuppression or bone marrow transplantation, the majority of affected males die within the first year of life of either metabolic derangements or sepsis; a few with a milder phenotype have survived into the second and third decade. IPEX syndrome is inherited in an X-linked manner.</p>
          </list-item>
          <list-item>
            <p><bold>Neonatal diabetes mellitus and cerebellar agenesis</bold> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/609069">OMIM</ext-link>) is caused by pathogenic variants in <italic toggle="yes">PTF1A</italic>, encoding pancreas transcription factor 1 alpha at 10p13 [<xref ref-type="bibr" rid="dmtn.REF.sellick.2004.1301">Sellick et al 2004</xref>]. The disorder is characterized by the combination of cerebellar agenesis and neonatal diabetes mellitus. Infants usually die within a few months of birth. Neonatal diabetes mellitus and cerebellar agenesis is inherited in an autosomal recessive manner.</p>
          </list-item>
          <list-item>
            <p><bold>Neonatal diabetes mellitus, annular pancreas, intestinal atresias, and gall bladder agenesis</bold> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/615710">OMIM</ext-link>) is caused by pathogenic variants in <italic toggle="yes">RFX6</italic>. A small number of affected individuals have been reported with various combinations of pancreatic hypoplasia, agenesis, or neonatal diabetes without clear evidence of abnormal pancreatic anatomy in association with gut atresias and gall bladder hypoplasia/atresia [<xref ref-type="bibr" rid="dmtn.REF.gal_ng_mez.2007.144">Gal&#x000e1;n-G&#x000f3;mez et al 2007</xref>]. The majority have died in the first year of life; however, some individuals are still living with normal development, although the follow up has not been long. This condition is inherited in an autosomal recessive manner.</p>
          </list-item>
          <list-item>
            <p><bold>Neonatal diabetes mellitus and congenital hypothyroidism caused by pathogenic variants in <italic toggle="yes">GLIS3</italic>.</bold> This rare condition is characterized by the combination of neonatal diabetes mellitus, congenital hypothyroidism, glaucoma, polycystic kidneys, cholestasis, and hepatic fibrosis. However, the findings can be variable and not all the features are reported in all cases. Some individuals have survived infancy; mild intellectual disability has been reported [<xref ref-type="bibr" rid="dmtn.REF.sen_e.2006.682">Sen&#x000e9;e et al 2006</xref>] (see also <related-object link-type="booklink" source-id="gene" document-id="hepatic-fibrosis" document-type="chapter">Congenital Hepatic Fibrosis Overview</related-object>). This condition is inherited in an autosomal recessive manner.</p>
          </list-item>
          <list-item>
            <p><bold>Neonatal diabetes mellitus and congenital heart disease caused by pathogenic variants in</bold>
<bold><italic toggle="yes">GATA6</italic></bold> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/600001">OMIM</ext-link>)<bold>.</bold> The combination of congenital heart disease (ventricular septal defect) and pancreatic hypoplasia was first reported by <xref ref-type="bibr" rid="dmtn.REF.g_rson.1970.522">G&#x000fc;rson et al [1970]</xref>. <xref ref-type="bibr" rid="dmtn.REF.yorifuji.1994.331">Yorifuji et al [1994]</xref> reported a second Japanese family in which individuals in two generations had pancreatic hypoplasia, neonatal diabetes mellitus, and congenital heart disease. This condition is inherited in an autosomal dominant manner.</p>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="prs" document-type="chapter"><bold>Phosphoribosylpyrophosphate synthetase (PRS) superactivity</bold></related-object> has been reported as a cause of permanent neonatal diabetes mellitus. The male siblings reported by <xref ref-type="bibr" rid="dmtn.REF.christen.1992.1167">Christen et al [1992]</xref> also had intellectual disability and a progressive axonal neuropathy. PRS superactivity is inherited in an X-linked manner.</p>
          </list-item>
        </list>
      </sec>
      <sec id="dmtn.Management">
        <title>Management</title>
        <sec id="dmtn.Evaluations_Following_Initial_Diagn">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs in an individual diagnosed with 6q24-related transient neonatal diabetes mellitus (6q24-TNDM), the following evaluations are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Birth weight, length, and head circumference and any subsequent growth parameters</p>
            </list-item>
            <list-item>
              <p>General dysmorphology examination, preferably by a clinical geneticist including evaluation of tongue size and umbilicus</p>
            </list-item>
            <list-item>
              <p>Neurologic examination and developmental assessment</p>
            </list-item>
            <list-item>
              <p>Investigation of the anatomy of the pancreas by ultrasound examination or MRI</p>
            </list-item>
            <list-item>
              <p>Echocardiogram and ultrasound examination of the liver and kidneys to help identify those infants likely to have 6q24-TNDM caused by mutation of <italic toggle="yes">ZFP57</italic></p>
            </list-item>
            <list-item>
              <p>Brain MRI scan if evidence of developmental delay or hypotonia</p>
            </list-item>
            <list-item>
              <p>Serum glucose concentration</p>
            </list-item>
            <list-item>
              <p>C peptide measurement</p>
            </list-item>
            <list-item>
              <p>Pancreatic beta cell autoantibody measurements</p>
            </list-item>
            <list-item>
              <p>Liver function and thyroid function tests</p>
            </list-item>
            <list-item>
              <p>A pediatric endocrinology consultation for follow up of diabetes</p>
            </list-item>
            <list-item>
              <p>Clinical genetics consultation</p>
            </list-item>
          </list>
          <p>Patients with hypomethylation at imprinted loci (HIL) should be evaluated for hypotonia and other neurologic features including epilepsy, congenital heart disease, deafness, renal malformations, and pseudohypoparathyroidism with measurement of serum concentrations of calcium and phosphate and parathyroid hormone testing.</p>
        </sec>
        <sec id="dmtn.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>Rehydration and IV insulin on a sliding scale are usually required. Some infants produce some insulin and can be treated by rehydration alone.</p>
          <p>Subcutaneous injection of insulin is introduced as soon as possible, often within two weeks. Continuous insulin pump therapy (as opposed to intermittent insulin injections) has been used successfully in a number of cases in the UK and France [JP Shield, personal communication]. Successful treatment with subcutaneous insulin glargine has also been reported [<xref ref-type="bibr" rid="dmtn.REF.barone.2011.291">Barone et al 2011</xref>].</p>
          <p>Blood glucose concentration should be monitored and insulin doses changed accordingly as in the standard treatment for diabetes mellitus. Insulin can be discontinued when blood glucose concentrations stabilize.</p>
          <p>Once diabetes mellitus is in remission, parents need to be alerted to the possibility of recurrence of the diabetes mellitus, particularly during periods of illness. Symptoms such as excessive thirst, polyuria, and repeated bacterial infections should prompt measurement of blood glucose concentration.</p>
          <p>If diabetes mellitus recurs, treatment may require diet alone, oral agents, or insulin, although the doses of insulin needed tend to be less than those required in type 1 diabetes mellitus (i.e., some residual endogenous insulin remains). It should be noted that patients do not always require treatment with insulin even in the neonatal period. In several patients at relapse, sulphonylureas or diet alone is adequate [<xref ref-type="bibr" rid="dmtn.REF.valerio.2004.2405">Valerio et al 2004</xref>].</p>
          <p>Note: Macroglossia could potentially cause airway obstruction; macroglossia severe enough to require treatment has not been reported.</p>
        </sec>
        <sec id="dmtn.Prevention_of_Secondary_Complicatio">
          <title>Prevention of Secondary Complications</title>
          <p>The main concerns are related to failure to make the diagnosis soon enough. Dehydration secondary to hyperglycemia can cause serious long-term sequelae if not treated promptly. Therefore, rehydration is most important in the early stages of the disease.</p>
        </sec>
        <sec id="dmtn.Surveillance">
          <title>Surveillance</title>
          <p>Periodic glucose tolerance tests can be used to assess insulin secretion. Most children with transient neonatal diabetes mellitus in remission have no evidence of beta cell dysfunction or insulin resistance in the fasting state. Insulin response to intravenous glucose loading is often normal but suggests future recurrence if abnormal [<xref ref-type="bibr" rid="dmtn.REF.shield.2004.f341">Shield et al 2004</xref>].</p>
          <p>Measure growth (height, weight, head circumference) at regular intervals (i.e., at least every six months)</p>
          <p>Developmental assessment to identify any special educational needs is appropriate.</p>
          <p>Children with HIL need to be monitored for developmental delay and special educational needs.</p>
        </sec>
        <sec id="dmtn.AgentsCircumstances_to_Avoid">
          <title>Agents/Circumstances to Avoid</title>
          <p>General factors that predispose to late-onset diabetes (e.g., excessive weight gain) or risk factors for cardiovascular disorders should be avoided.</p>
        </sec>
        <sec id="dmtn.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>Recommendations vary by underlying genetic mechanism:</p>
          <list list-type="bullet">
            <list-item>
              <p>When the proband is identified as having TNDM caused by an inherited paternal 6q24 duplication, the sibs and offspring of the proband are at increased risk of inheriting the duplication. Screening for diabetes mellitus is appropriate for those infants who have inherited the paternal 6q24 duplication.</p>
            </list-item>
            <list-item>
              <p>For 6q24-TNDM caused by <italic toggle="yes">ZFP57</italic> pathogenic variants, sibs are at a 25% risk for the same condition, although the clinical findings can be variable.</p>
            </list-item>
            <list-item>
              <p>Although individuals reported to have 6q24-TNDM as the result of an imprinting center epimutation have been simplex cases (i.e., a single occurrence in a family), it is not clear if all cases are <italic toggle="yes">de novo</italic> (see also <xref ref-type="sec" rid="dmtn.Genetic_Counseling">Genetic Counseling</xref>).</p>
              <list list-type="bullet">
                <list-item>
                  <p>Screening the mother and sibs of these individuals for diabetes mellitus may be appropriate.</p>
                </list-item>
                <list-item>
                  <p>Offspring of female probands with 6q24-TNDM caused by a hypomethylation of the maternal <italic toggle="yes">PLAGL1/HYMAI</italic> differentially methylated region (DMR) may be at risk of having 6q24-TNDM or of developing diabetes mellitus later in life and should be offered testing.</p>
                </list-item>
              </list>
            </list-item>
          </list>
          <p>See <xref ref-type="sec" rid="dmtn.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="dmtn.Pregnancy_Management">
          <title>Pregnancy Management</title>
          <p>There are no specific guidelines on pregnancy management for women with a history of 6q24-TNDM. However, it is important to inform health professionals during the pregnancy of a susceptibility to diabetes. Rarely some affected women with classic 6q24-TNDM genetic aberrations (e.g., duplication of 6q24, paternal UPD 6, methylation mutations) will develop gestational diabetes; therefore, pregnancy is thought to be a risk factor for recurrence of diabetes.</p>
          <p>If prenatal diagnosis identifies an affected fetus, fetal growth is anticipated to lag during the third trimester.</p>
        </sec>
        <sec id="dmtn.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p>
        </sec>
      </sec>
      <sec id="dmtn.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="dmtn.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>6q24-related transient neonatal diabetes mellitus (6q24-TNDM) results from overexpression of imprinted genes at 6q24 (<italic toggle="yes">PLAGL1</italic> and <italic toggle="yes">HYMAI</italic>). Three different genetic mechanisms cause 6q24-TNDM:</p>
          <list list-type="bullet">
            <list-item>
              <p>Paternal uniparental disomy of chromosome 6 (41%)</p>
              <list list-type="bullet">
                <list-item>
                  <p>Both complete and partial paternal uniparental disomy of chromosome 6 are typically <italic toggle="yes">de novo</italic> events.</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>Duplication of 6q24 on the paternal allele (29%)</p>
              <list list-type="bullet">
                <list-item>
                  <p>Paternal duplication of 6q24 can be occur <italic toggle="yes">de novo</italic> or be inherited. Occasionally the duplication can arise as part of a complex chromosomal rearrangement in a parent.</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>Hypomethylation of the maternal <italic toggle="yes">PLAGL1/HYMAI</italic> DMR thereby losing the methylation that typically silences the maternal region (30%)</p>
              <list list-type="bullet">
                <list-item>
                  <p>Maternal <italic toggle="yes">PLAGL1</italic> DMR hypomethylation can result from an imprinting mutation of the promoter <italic toggle="yes">PLAGL1</italic> DMR (isolated) or as part of a generalized &#x02018;hypomethylation at imprinted loci&#x02019; (HIL); biallelic (homozygous or compound heterozygous) <italic toggle="yes">ZFP57</italic> pathogenic variants account for almost half of TNDM-HIL.</p>
                </list-item>
              </list>
            </list-item>
          </list>
        </sec>
        <sec id="dmtn.Risk_to_Family_Members__Paternal_Un">
          <title>Risk to Family Members &#x02014; Paternal Uniparental Disomy of Chromosome 6</title>
          <p>
            <bold>Parents, sibs, and offspring of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The risk to parents, sibs, and offspring of a proband with TNDM caused by paternal UPD6 is unlikely to be higher than the risk to the general population, as paternal UPD6 is a <italic toggle="yes">de novo</italic>, typically non-recurrent event.</p>
            </list-item>
            <list-item>
              <p>If the proband has a chromosome abnormality in addition to paternal UPD6, the risk to parents, sibs, and offspring is related to the specific abnormality identified in the proband.</p>
            </list-item>
          </list>
        </sec>
        <sec id="dmtn.Risk_to_Family_Members__Paternal_In">
          <title>Risk to Family Members &#x02014; Paternal Inherited/Derived Duplication of 6q24 &#x02014; Usually Submicroscopic Tandem Duplication</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The father of a proband may have the (submicroscopic or visible) 6q24 duplication identified in the proband and may be at risk of developing diabetes mellitus in later life (or having had a history of early diabetes mellitus) <bold>if</bold> the 6q24 duplication was inherited from his father.</p>
            </list-item>
            <list-item>
              <p>Alternatively, the 6q24 duplication may be a <italic toggle="yes">de novo</italic> occurrence in the proband.</p>
            </list-item>
            <list-item>
              <p>Recommendations for the evaluation of the father of a proband with 6q24-TNDM include routine cytogenetic analysis and molecular genetic testing to identify a 6q24 duplication if present, and to exclude a balanced/unbalanced translocation involving the 6q24 critical region.</p>
            </list-item>
          </list>
          <p><bold>Sibs of a proband.</bold> The risk to the sibs of a proband depends on the genetic status of the father:</p>
          <list list-type="bullet">
            <list-item>
              <p>If the father <bold>does not</bold> have a duplication of 6q24, the risk to the sibs depends on the possibility of germline mosaicism in the father (estimated risk: ~1%).</p>
            </list-item>
            <list-item>
              <p>If the father has the 6q24 duplication, the risk to each sib of inheriting the duplication is 50%. Because of reduced penetrance, sibs who inherit the paternal 6q24 duplication may not develop TNDM, but they are at increased risk of developing diabetes mellitus later in life.</p>
            </list-item>
            <list-item>
              <p>If the father has a complex chromosomal rearrangement involving 6q24, the risk to sibs is related to the specific rearrangement.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a male proband.</bold> Each child of a male with 6q24-TNDM caused by duplication of 6q24 has a 50% chance of inheriting the duplication and is at high risk of developing 6q24-TNDM and/or diabetes mellitus later in life.</p>
          <p><bold>Offspring of a female proband.</bold> Each child of a female with 6q24-TNDM caused by duplication of 6q24 has a 50% chance of inheriting the duplication but is not at increased risk of developing 6q24-TNDM or diabetes mellitus later in life.</p>
          <p><bold>Other family members of a proband.</bold> The risk to more distant family members depends on the status of the proband's parents. Family members may be at risk if the proband has an inherited duplication of 6q24.</p>
        </sec>
        <sec id="dmtn.Risk_to_Family_Members__Hypomethyla">
          <title>Risk to Family Members &#x02014; Hypomethylation of the Maternal <italic toggle="yes">PLAGL1/HYMAI</italic> DMR</title>
          <p>Risks depend on the underlying cause of the hypomethylation.</p>
          <sec id="dmtn.Proband_with_Isolated_Hypomethylati">
            <title>Proband with Isolated Hypomethylation at TNDM-DMR</title>
            <p><bold>Parents of a proband.</bold> Parents of a proband with 6q24-TNDM caused by isolated DMR hypomethylation have not been reported as having a similar finding, as having neonatal diabetes mellitus, or as developing it later in life.</p>
            <p>
              <bold>Sibs of a proband</bold>
            </p>
            <list list-type="bullet">
              <list-item>
                <p>Sibs of a proband with 6q24-TNDM caused by isolated DMR hypomethylation are not reported to have an increased risk of having 6q24-TNDM or of developing diabetes mellitus.</p>
              </list-item>
              <list-item>
                <p>Because the cause of isolated hypomethylation at the DMR (imprinting center) is not understood and it is possible that it is not <italic toggle="yes">de novo</italic> in all families, testing of sibs of a proband for diabetes is appropriate.</p>
              </list-item>
            </list>
            <p><bold>Offspring of a proband.</bold> The risk to the offspring of individuals with 6q24-TNDM caused by isolated hypomethylation of the imprinting center of developing 6q24-TNDM or diabetes mellitus later in life is unknown but may be higher in offspring of a female proband (theoretic based on the possibility of the hypomethylation being secondary to an as-yet undiscovered deletion on the maternal allele which could be inherited).</p>
          </sec>
          <sec id="dmtn.Hypomethylation_at_Imprinted_Loci_H">
            <title>Hypomethylation at Imprinted Loci (HIL) as a Result of Biallelic Pathogenic Variants in <italic toggle="yes">ZFP57</italic></title>
            <p>
              <bold>Parents of a proband</bold>
            </p>
            <list list-type="bullet">
              <list-item>
                <p>The parents of an affected child are obligate heterozygotes (i.e., carriers of one mutant <italic toggle="yes">ZFP57</italic> allele). In highly consanguineous families a parent may also be homozygous rather than heterozygous. This finding has been reported in at least one family [<xref ref-type="bibr" rid="dmtn.REF.mackay.2008.949">Mackay et al 2008</xref>].</p>
              </list-item>
              <list-item>
                <p>Parents heterozygous for <italic toggle="yes">ZFP57</italic> pathogenic variants are not known to be at risk of developing diabetes mellitus. No phenotype has yet been reported in heterozygotes.</p>
              </list-item>
            </list>
            <p>
              <bold>Sibs of a proband</bold>
            </p>
            <list list-type="bullet">
              <list-item>
                <p>At conception, each sib of an affected individual has a 25% chance of inheriting two <italic toggle="yes">ZFP57</italic> pathogenic variants and being at risk of developing 6q24-TNDM (although clinical findings in sibs can be variable), a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier.</p>
              </list-item>
              <list-item>
                <p>In sibs who have inherited two <italic toggle="yes">ZFP57</italic> pathogenic variants, the risk of developing 6q24-TNDM is not known but may be high. The non-diabetes manifestations are variable. Affected sibs, of whom one was severely developmentally delayed and the other only mildly delayed, have been reported [<xref ref-type="bibr" rid="dmtn.REF.boonen.2008.453">Boonen et al 2008</xref>]. At least one person homozygous for <italic toggle="yes">ZFP57</italic> pathogenic variants had a normal phenotype [<xref ref-type="bibr" rid="dmtn.REF.mackay.2008.949">Mackay et al 2008</xref>].</p>
              </list-item>
            </list>
            <p><bold>Offspring of a proband</bold>. The offspring of an individual with biallelic pathogenic variants in <italic toggle="yes">ZFP57</italic> are obligate heterozygotes (carriers) for a <italic toggle="yes">ZFP57</italic> pathogenic variant.</p>
            <p><bold>Other family members of a proband.</bold> Each sib of the proband&#x02019;s parents is at a 50% risk of being a carrier of a <italic toggle="yes">ZFP57</italic> pathogenic variant.</p>
            <p><bold>Carrier detection.</bold> Carrier testing using molecular genetic techniques is not offered unless the familial pathogenic variant is known.</p>
          </sec>
          <sec id="dmtn.Hypomethylation_at_Imprinted_Loci_H_1">
            <title>Hypomethylation at Imprinted Loci (HIL) with No Pathogenic Variants Identified in <italic toggle="yes">ZFP57</italic></title>
            <p>The risks to sibs, offspring, and parents are unknown as recurrence has not as yet been reported in this subgroup.</p>
            <p>Note: There is an increased incidence of assisted reproductive technology used by the parents of these probands; whether a causal relationship exists between ART and hypomethylation is not clear [<xref ref-type="bibr" rid="dmtn.REF.mackay.2008.949">Mackay et al 2008</xref>].</p>
          </sec>
        </sec>
        <sec id="dmtn.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p>See Management, <xref ref-type="sec" rid="dmtn.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</xref> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk, clarification of carrier status, and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected, are carriers, or are at risk of being carriers.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="dmtn.Prenatal_Testing">
          <title>Prenatal Testing</title>
          <p>Consideration of prenatal diagnosis for 6q24-TNDM depends on the genetic mechanism in the family: paternal UPD6 is typically a <italic toggle="yes">de novo</italic>, non-recurrent event; dup6q24 may recur when the duplication is inherited from the father; and hypomethylation at imprinted loci caused by biallelic <italic toggle="yes">ZFP57</italic> pathogenic variants is inherited in an autosomal recessive manner. Counseling by a genetics professional is strongly recommended.</p>
          <p><bold>Prenatal diagnosis and preimplantation genetic diagnosis (PGD)</bold> for pregnancies at risk for:</p>
          <list list-type="bullet">
            <list-item>
              <p>Paternal duplication 6q24 requires prior identification of the structural chromosome abnormality in the family.</p>
            </list-item>
            <list-item>
              <p>Hypomethylation of the maternal <italic toggle="yes">PLAGL1/HYMAI</italic> DMR as a result of biallelic <italic toggle="yes">ZFP57</italic> pathogenic variants requires prior identification of the <italic toggle="yes">ZFP57</italic> pathogenic variants in the family. However, the phenotype associated with biallelic <italic toggle="yes">ZFP57</italic> pathogenic variants is variable and cannot be accurately predicted by the results of prenatal molecular genetic testing.</p>
            </list-item>
          </list>
        </sec>
      </sec>
      <sec id="dmtn.Resources">
        <title>Resources</title>
      </sec>
      <sec id="dmtn.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <sec id="dmtn.Molecular_Genetic_Pathogenesis">
          <title>Molecular Genetic Pathogenesis</title>
          <p>The molecular pathogenesis of 6q24-TNDM is not yet understood. The minimal disease-associated region has been refined [<xref ref-type="bibr" rid="dmtn.REF.docherty.2010.2347">Docherty et al 2010</xref>] excluding all but <italic toggle="yes">PLAGL1</italic> and <italic toggle="yes">HYMAI</italic> as candidate genes for 6q24. Maternal alleles are methylated within the DMR (imprinting center) of <italic toggle="yes">PLAGL1</italic> (<italic toggle="yes">ZAC</italic>) and <italic toggle="yes">HYMAI</italic>, thereby silencing their expression. Paternal alleles are not methylated and are expressed. Pathogenic alleles have either lost the methylation imprint that silences the maternal allele or have a rearrangement that results in duplication and overexpression of paternal alleles. See <xref ref-type="sec" rid="dmtn.Establishing_the_Diagnosis">Establishing the Diagnosis</xref> for genetic mechanisms.</p>
          <p>All mechanisms described in relation to 6q24-TNDM result in overexpression of <italic toggle="yes">PLAGL1</italic>. In most human fetal tissues, <italic toggle="yes">PLAGL1</italic> is expressed only from the paternal allele because of the lack of paternal methylation within the differentially methylated region (DMR) of the fetal promoter of the gene [<xref ref-type="bibr" rid="dmtn.REF.varrault.2001.18653">Varrault et al 2001</xref>]. No enhancers or insulators of the region have been identified. In adult tissues imprinted expression is present only in a minority of tissues such as skin fibroblasts. Biallelic expression results from an alternative non-imprinted promoter, 55 kb upstream of the imprinted promoter [<xref ref-type="bibr" rid="dmtn.REF.valleley.2007.972">Valleley et al 2007</xref>]. Many <italic toggle="yes">PLAGL1</italic> transcript variants differing in the 5' UTR and encoding two different isoforms are known for this gene.</p>
          <p>The mechanism whereby <italic toggle="yes">PLAGL1</italic> overexpression causes early diabetes mellitus from which an individual eventually recovers is not fully understood. <italic toggle="yes">PLAGL1</italic> codes for a zinc finger protein and overexpression is known to lead to cell cycle arrest and apoptosis in cell lines; <italic toggle="yes">PLAGL1</italic> regulates the pituitary adenylate cyclase-activating polypeptide receptor (PACAP1) which is known to stimulate insulin secretion. Downstream targets of <italic toggle="yes">PLAGL1</italic> are not fully characterized although <xref ref-type="bibr" rid="dmtn.REF.arima.2005.2650">Arima et al [2005]</xref> showed that <italic toggle="yes">PLAGL1</italic> binds to the CpG island in <italic toggle="yes">KCNQ1OT1</italic>, which negatively regulates <italic toggle="yes">CDKN1C</italic>. <xref ref-type="bibr" rid="dmtn.REF.varrault.2006.711">Varrault et al [2006]</xref> showed that <italic toggle="yes">PLAGL1</italic> is an important member of a cellular network of imprinted genes involved in fetal growth.</p>
          <p>A mouse model for TNDM [<xref ref-type="bibr" rid="dmtn.REF.ma.2004.339">Ma et al 2004</xref>] demonstrated impaired glucose homeostasis in mice with overexpression of <italic toggle="yes">plagl1</italic> and showed a downregulation of pdx-1, a key transcription factor vital for normal pancreatic development. Although beta cell mass was reduced in fetal mice, it had recovered by the time of birth; nonetheless, insulin response to hyperglycemia was decreased. It is hypothesized that the beta cell mass is not sufficient to respond during times of excessive physiologic stress, resulting in &#x02018;breakthrough&#x02019; diabetes with intercurrent illnesses and sometimes with increasing age.</p>
          <p>In keeping with this hypothesis, <xref ref-type="bibr" rid="dmtn.REF.valerio.2004.2405">Valerio et al [2004]</xref> have demonstrated in 6q24-TNDM a specific defect of insulin secretion after glucose stimulation. Furthermore, insulin secretion is possible through the stimulatory G protein pathway.</p>
          <p>At the molecular level, the picture is complicated by <italic toggle="yes">HYMAI,</italic> which overlaps <italic toggle="yes">PLAGL1</italic> and the 6q24-TNDM DMR, which is also only expressed paternally. <italic toggle="yes">HYMAI</italic> lacks an open reading frame and is not translated. It may regulate <italic toggle="yes">PLAGL1</italic> expression; its relationship to <italic toggle="yes">PLAGL1</italic> and 6q24-TNDM is not yet known.</p>
          <p>In fibroblasts from an individual with transient neonatal diabetes mellitus, the monoallelic expression of both <italic toggle="yes">PLAGL1</italic> and <italic toggle="yes">HYMAI</italic> was found to be relaxed, providing strong supportive evidence that the presence of two unmethylated alleles of this locus is indeed associated with the inappropriate expression of neighboring genes [<xref ref-type="bibr" rid="dmtn.REF.mackay.2002.139">Mackay et al 2002</xref>].The <italic toggle="yes">PLAGL1</italic> promoter is localized to the CpG island harboring the methylation imprint associated with 6q24-TNDM, and methylation of this promoter silences its activity [<xref ref-type="bibr" rid="dmtn.REF.varrault.2001.18653">Varrault et al 2001</xref>].</p>
          <p><bold>Gene structure.</bold> The transcript <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_001109809.2">NM_001109809.2</ext-link> has four coding exons. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="dmtn" object-id="dmtn.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
          <p><bold>Pathogenic allelic variants.</bold>
<italic toggle="yes">ZFP67</italic> missense, nonsense, and frameshift pathogenic variants have been identified [<xref ref-type="bibr" rid="dmtn.REF.mackay.2008.949">Mackay et al 2008</xref>].</p>
          <p><bold>Normal gene product.</bold> The protein product (ZFP57; <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_001103279.2">NP_001103279.2</ext-link>) of <italic toggle="yes">ZFP57</italic> has 53 amino acid residues. It is a Kruppel-associated box (KRAB)-containing protein with seven zinc fingers that functions as a transcriptional regulator.</p>
          <p><bold>Abnormal gene product.</bold> Biallelic pathogenic <italic toggle="yes">ZFP57</italic> variants result in inactivation of ZFP57, a protein important in maintaining genomic imprinting at the DMR of <italic toggle="yes">PLAGL1</italic> and <italic toggle="yes">HYMAI</italic>.</p>
        </sec>
      </sec>
      <sec id="dmtn.References">
        <title>References</title>
        <sec id="dmtn.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="dmtn.Literature_Cited.reflist0">
            <ref id="dmtn.REF.arima.2005.2650">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Arima</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kamikihara</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hayashida</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kato</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Inoue</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shirayoshi</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oshimura</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Soejima</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mukai</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wake</surname>
                    <given-names>N</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>ZAC, LIT1 (KCNQ1OT1) and p57KIP2 (CDKN1C) are in an imprinted gene network that may play a role in Beckwith-Wiedemann syndrome.</article-title>
                <source>Nucleic Acids Res</source>
                <volume>33</volume>
                <fpage>2650</fpage>
                <lpage>60</lpage>
                <pub-id pub-id-type="pmid">15888726</pub-id>
              </element-citation>
            </ref>
            <ref id="dmtn.REF.arthur.1997.417">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Arthur</surname>
                    <given-names>EI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zlotogora</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lerer</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dagan</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marks</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abeliovich</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <article-title>Transient neonatal diabetes mellitus in a child with invdup (6)(q22&#x02013;q23) of paternal origin.</article-title>
                <source>Eur J Hum Genet.</source>
                <year>1997</year>
                <volume>5</volume>
                <fpage>417</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">9450188</pub-id>
              </element-citation>
            </ref>
            <ref id="dmtn.REF.barone.2011.291">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Barone</surname>
                    <given-names>JV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tillman</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferry</surname>
                    <given-names>RJ</given-names>
                    <suffix>Jr</suffix>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Treatment of transient neonatal diabetes mellitus with subcutaneous insulin glargine in an extremely low birth weight neonate.</article-title>
                <source>J Pediatr Pharmacol Ther</source>
                <volume>16</volume>
                <fpage>291</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">22768014</pub-id>
              </element-citation>
            </ref>
            <ref id="dmtn.REF.boonen.2008.453">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Boonen</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>P&#x000f6;rksen</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mackay</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oestergaard</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Olsen</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brondum-Nielsen</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Temple</surname>
                    <given-names>IK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hahnemann</surname>
                    <given-names>JM</given-names>
                  </name>
                </person-group>
                <article-title>Clinical characterisation of the multiple maternal hypomethylation syndrome in siblings.</article-title>
                <source>Eur J Hum Genet.</source>
                <year>2008</year>
                <volume>16</volume>
                <fpage>453</fpage>
                <lpage>61</lpage>
                <pub-id pub-id-type="pmid">18197189</pub-id>
              </element-citation>
            </ref>
            <ref id="dmtn.REF.cav_.2000.108">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cav&#x000e9;</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Polak</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Drunat</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Denamur</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Czernichow</surname>
                    <given-names>P.</given-names>
                  </name>
                </person-group>
                <article-title>Refinement of the 6q chromosomal region implicated in transient neonatal diabetes.</article-title>
                <source>Diabetes.</source>
                <year>2000</year>
                <volume>49</volume>
                <fpage>108</fpage>
                <lpage>13</lpage>
                <pub-id pub-id-type="pmid">10615957</pub-id>
              </element-citation>
            </ref>
            <ref id="dmtn.REF.christen.1992.1167">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Christen</surname>
                    <given-names>HJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hanefeld</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Duley</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Simmonds</surname>
                    <given-names>HA</given-names>
                  </name>
                </person-group>
                <year>1992</year>
                <article-title>Distinct neurological syndrome in two brothers with hyperuricaemia.</article-title>
                <source>Lancet</source>
                <volume>340</volume>
                <fpage>1167</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">1359249</pub-id>
              </element-citation>
            </ref>
            <ref id="dmtn.REF.diatloffzito.2007.31">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Diatloff-Zito</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nicole</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marcelin</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Labit</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marquis</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bellann&#x000e9;-Chantelot</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robert</surname>
                    <given-names>JJ</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Genetic and epigenetic defects at the 6q24 imprinted locus in a cohort of 13 patients with transient neonatal diabetes: new hypothesis raised by the finding of a unique case with hemizygotic deletion in the critical region.</article-title>
                <source>J Med Genet</source>
                <volume>44</volume>
                <fpage>31</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">16971482</pub-id>
              </element-citation>
            </ref>
            <ref id="dmtn.REF.docherty.2010.2347">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Docherty</surname>
                    <given-names>LE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poole</surname>
                    <given-names>RL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mattocks</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lehmann</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Temple</surname>
                    <given-names>IK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mackay</surname>
                    <given-names>DJ</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Further refinement of the critical minimal genetic region for the imprinting disorder 6q24 transient neonatal diabetes.</article-title>
                <source>Diabetologia</source>
                <volume>53</volume>
                <fpage>2347</fpage>
                <lpage>51</lpage>
                <pub-id pub-id-type="pmid">20668833</pub-id>
              </element-citation>
            </ref>
            <ref id="dmtn.REF.docherty.2013.758">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Docherty</surname>
                    <given-names>LE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kabwama</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lehmann</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hawke</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harrison</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Flanagan</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ellard</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hattersley</surname>
                    <given-names>AT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shield</surname>
                    <given-names>JPH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ennis</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mackay</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Temple</surname>
                    <given-names>IK</given-names>
                  </name>
                </person-group>
                <article-title>6q24 Transient Neonatal Diabetes Mellitus (6q24 TNDM) &#x02013; clinical presentation and genotype phenotype correlation in an international cohort of cases.</article-title>
                <source>Diabetologia</source>
                <year>2013</year>
                <volume>56</volume>
                <fpage>758</fpage>
                <lpage>62</lpage>
                <pub-id pub-id-type="pmid">23385738</pub-id>
              </element-citation>
            </ref>
            <ref id="dmtn.REF.edghill.2006.1301">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Edghill</surname>
                    <given-names>EL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bingham</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Slingerland</surname>
                    <given-names>AS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Minton</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Noordam</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ellard</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hattersley</surname>
                    <given-names>AT</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Hepatocyte nuclear factor-1 beta mutations cause neonatal diabetes and intrauterine growth retardation: support for a critical role of HNF-1beta in human pancreatic development.</article-title>
                <source>Diabet Med</source>
                <volume>23</volume>
                <fpage>1301</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">17116179</pub-id>
              </element-citation>
            </ref>
            <ref id="dmtn.REF.edghill.2008.1034">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Edghill</surname>
                    <given-names>EL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Flanagan</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patch</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boustred</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parrish</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shields</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shepherd</surname>
                    <given-names>MH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hussain</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kapoor</surname>
                    <given-names>RR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malecki</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>MacDonald</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>St&#x000f8;y</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steiner</surname>
                    <given-names>DF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Philipson</surname>
                    <given-names>LH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bell</surname>
                    <given-names>GI</given-names>
                  </name>
                  <collab>Neonatal Diabetes International Collaborative Group</collab>
                </person-group>
                <article-title>Hattersley AT, Ellard S. Insulin mutation screening in 1,044 patients with diabetes: mutations in the INS gene are a common cause of neonatal diabetes but a rare cause of diabetes diagnosed in childhood or adulthood.</article-title>
                <source>Diabetes.</source>
                <year>2008</year>
                <volume>57</volume>
                <fpage>1034</fpage>
                <lpage>42</lpage>
                <pub-id pub-id-type="pmid">18162506</pub-id>
              </element-citation>
            </ref>
            <ref id="dmtn.REF.flanagan.2007.1930">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Flanagan</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patch</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mackay</surname>
                    <given-names>DJG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Edghill</surname>
                    <given-names>EL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gloyn</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robinson</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shield</surname>
                    <given-names>JPH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Temple</surname>
                    <given-names>IK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ellard</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hattersley</surname>
                    <given-names>AT</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Mutations in KATP channel genes cause transient neonatal diabetes and permanent diabetes in childhood or adulthood.</article-title>
                <source>Diabetes.</source>
                <volume>56</volume>
                <fpage>1930</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">17446535</pub-id>
              </element-citation>
            </ref>
            <ref id="dmtn.REF.gal_ng_mez.2007.144">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gal&#x000e1;n-G&#x000f3;mez</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>S&#x000e1;nchez</surname>
                    <given-names>EB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arias-Castro</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cardesa-Garc&#x000ed;a</surname>
                    <given-names>JJ</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Intrauterine growth retardation, duodenal and extrahepatic biliary atresia, hypoplastic pancreas and other intestinal anomalies: further evidence of the Mart&#x000ed;nez-Fr&#x000ed;as syndrome.</article-title>
                <source>Eur J Med Genet</source>
                <volume>50</volume>
                <fpage>144</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">17321227</pub-id>
              </element-citation>
            </ref>
            <ref id="dmtn.REF.gloyn.2006.824">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gloyn</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Diatloff-Zito</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Edghill</surname>
                    <given-names>EL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bellann&#x000e9;-Chantelot</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nivot</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coutant</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ellard</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hattersley</surname>
                    <given-names>AT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robert</surname>
                    <given-names>JJ</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>KCNJ11 activating mutations are associated with developmental delay, epilepsy and neonatal diabetes syndrome and other neurological features.</article-title>
                <source>Eur J Hum Genet</source>
                <volume>14</volume>
                <fpage>824</fpage>
                <lpage>30</lpage>
                <pub-id pub-id-type="pmid">16670688</pub-id>
              </element-citation>
            </ref>
            <ref id="dmtn.REF.gloyn.2004.1838">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gloyn</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pearson</surname>
                    <given-names>ER</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Antcliff</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Proks</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bruining</surname>
                    <given-names>GJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Slingerland</surname>
                    <given-names>AS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Howard</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Srinivasan</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Silva</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Molnes</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Edghill</surname>
                    <given-names>EL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frayling</surname>
                    <given-names>TM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Temple</surname>
                    <given-names>IK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mackay</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shield</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sumnik</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Rhijn</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wales</surname>
                    <given-names>JK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clark</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gorman</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aisenberg</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ellard</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Njolstad</surname>
                    <given-names>PR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ashcroft</surname>
                    <given-names>FM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hattersley</surname>
                    <given-names>AT</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes.</article-title>
                <source>N Engl J Med</source>
                <volume>350</volume>
                <fpage>1838</fpage>
                <lpage>49</lpage>
                <pub-id pub-id-type="pmid">15115830</pub-id>
              </element-citation>
            </ref>
            <ref id="dmtn.REF.gloyn.2005.925">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gloyn</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reimann</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Girard</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Edghill</surname>
                    <given-names>EL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Proks</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pearson</surname>
                    <given-names>ER</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Temple</surname>
                    <given-names>IK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mackay</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shield</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Freedenberg</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Noyes</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ellard</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ashcroft</surname>
                    <given-names>FM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gribble</surname>
                    <given-names>FM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hattersley</surname>
                    <given-names>AT</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Relapsing diabetes can result from moderately activating mutations in KCNJ11.</article-title>
                <source>Hum Mol Genet</source>
                <volume>14</volume>
                <fpage>925</fpage>
                <lpage>34</lpage>
                <pub-id pub-id-type="pmid">15718250</pub-id>
              </element-citation>
            </ref>
            <ref id="dmtn.REF.g_rson.1970.522">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>G&#x000fc;rson</surname>
                    <given-names>CT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tahsinoglu</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yakacikli</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ertugrul</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <article-title>A case of agenesis of the dorsal pancreas with interventricular septal defect in an infant.</article-title>
                <source>Helv Paediatr Acta.</source>
                <year>1970</year>
                <volume>25</volume>
                <fpage>522</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">5493568</pub-id>
              </element-citation>
            </ref>
            <ref id="dmtn.REF.ma.2004.339">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ma</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shield</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dean</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leclerc</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Knauf</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burcelin</surname>
                    <given-names>RR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rutter</surname>
                    <given-names>GA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kelsey</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Impaired glucose homeostasis in transgenic mice expressing the human transient neonatal diabetes mellitus locus, TNDM.</article-title>
                <source>J Clin Invest</source>
                <volume>114</volume>
                <fpage>339</fpage>
                <lpage>48</lpage>
                <pub-id pub-id-type="pmid">15286800</pub-id>
              </element-citation>
            </ref>
            <ref id="dmtn.REF.mackay.2014">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mackay</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bens</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Perez de Nanclares</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Siebert</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Temple</surname>
                    <given-names>IK</given-names>
                  </name>
                </person-group>
                <article-title>Clinical utility gene card for: Transient Neonatal Diabetes Mellitus, 6q24-related.</article-title>
                <source>Eur J Hum Genet.</source>
                <year>2014</year>
                <volume>22</volume>
                <issue>9</issue>
                <pub-id pub-id-type="pmid">24569603</pub-id>
              </element-citation>
            </ref>
            <ref id="dmtn.REF.mackay.2008.949">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mackay</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Callaway</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marks</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>White</surname>
                    <given-names>HE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Acerini</surname>
                    <given-names>CL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boonen</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dayanikli</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Firth</surname>
                    <given-names>HV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goodship</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haemers</surname>
                    <given-names>AP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hahnemann</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kordonouri</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Masoud</surname>
                    <given-names>AF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oestergaard</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Storr</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ellard</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hattersley</surname>
                    <given-names>AT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robinson</surname>
                    <given-names>DO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Temple</surname>
                    <given-names>IK</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Hypomethylation of multiple imprinted loci in individuals with transient neonatal diabetes is associated with mutations in ZFP57.</article-title>
                <source>Nat Genet</source>
                <volume>40</volume>
                <fpage>949</fpage>
                <lpage>51</lpage>
                <pub-id pub-id-type="pmid">18622393</pub-id>
              </element-citation>
            </ref>
            <ref id="dmtn.REF.mackay.2002.139">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mackay</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coupe</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shield</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Storr</surname>
                    <given-names>JN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Temple</surname>
                    <given-names>IK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robinson</surname>
                    <given-names>DO</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Relaxation of imprinted expression of ZAC and HYMAI in a patient with transient neonatal diabetes mellitus.</article-title>
                <source>Hum Genet</source>
                <volume>110</volume>
                <fpage>139</fpage>
                <lpage>44</lpage>
                <pub-id pub-id-type="pmid">11935319</pub-id>
              </element-citation>
            </ref>
            <ref id="dmtn.REF.mackay.2005.255">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mackay</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Temple</surname>
                    <given-names>IK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shield</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robinson</surname>
                    <given-names>DO</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Bisulphite sequencing of the transient neonatal diabetes mellitus DMR facilitates a novel diagnostic test but reveals no methylation anomalies in patients of unknown aetiology.</article-title>
                <source>Hum Genet</source>
                <volume>116</volume>
                <fpage>255</fpage>
                <lpage>61</lpage>
                <pub-id pub-id-type="pmid">15635480</pub-id>
              </element-citation>
            </ref>
            <ref id="dmtn.REF.metz.2002.483">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Metz</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cav&#x000e9;</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertrand</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Deffert</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gueguen-Giroux</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Czernichow</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Polak</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Neonatal diabetes mellitus: chromosomal analysis in transient and permanent cases.</article-title>
                <source>J Pediatr</source>
                <volume>141</volume>
                <fpage>483</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">12378186</pub-id>
              </element-citation>
            </ref>
            <ref id="dmtn.REF.nj_lstad.2003.2854">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nj&#x000f8;lstad</surname>
                    <given-names>PR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sagen</surname>
                    <given-names>JV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bj&#x000f8;rkhaug</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Odili</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shehadeh</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bakry</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sarici</surname>
                    <given-names>SU</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alpay</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Molnes</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Molven</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>S&#x000f8;vik</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matschinsky</surname>
                    <given-names>FM</given-names>
                  </name>
                </person-group>
                <article-title>Permanent neonatal diabetes caused by glucokinase deficiency: inborn error of the glucose-insulin signaling pathway.</article-title>
                <source>Diabetes.</source>
                <year>2003</year>
                <volume>52</volume>
                <fpage>2854</fpage>
                <lpage>60</lpage>
                <pub-id pub-id-type="pmid">14578306</pub-id>
              </element-citation>
            </ref>
            <ref id="dmtn.REF.nj_lstad.2001.1588">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nj&#x000f8;lstad</surname>
                    <given-names>PR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>S&#x000f8;vik</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cuesta-Mu&#x000f1;oz</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bj&#x000f8;rkhaug</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Massa</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barbetti</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Undlien</surname>
                    <given-names>DE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shiota</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Magnuson</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Molven</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matschinsky</surname>
                    <given-names>FM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bell</surname>
                    <given-names>GI</given-names>
                  </name>
                </person-group>
                <article-title>Neonatal diabetes mellitus due to complete glucokinase deficiency.</article-title>
                <source>N Engl J Med.</source>
                <year>2001</year>
                <volume>344</volume>
                <fpage>1588</fpage>
                <lpage>92</lpage>
                <pub-id pub-id-type="pmid">11372010</pub-id>
              </element-citation>
            </ref>
            <ref id="dmtn.REF.polak.2007.12">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Polak</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cav&#x000e9;</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Neonatal diabetes mellitus: a disease linked to multiple mechanisms.</article-title>
                <source>Orphanet J Rare Dis</source>
                <volume>2</volume>
                <fpage>12</fpage>
                <pub-id pub-id-type="pmid">17349054</pub-id>
              </element-citation>
            </ref>
            <ref id="dmtn.REF.polak.2004.59">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Polak</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shield</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Neonatal and very-early-onset diabetes mellitus.</article-title>
                <source>Semin Neonatol</source>
                <volume>9</volume>
                <fpage>59</fpage>
                <lpage>65</lpage>
                <pub-id pub-id-type="pmid">15013476</pub-id>
              </element-citation>
            </ref>
            <ref id="dmtn.REF.proks.2007.2011">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Proks</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shimomura</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Craig</surname>
                    <given-names>TJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Girard</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ashcroft</surname>
                    <given-names>FM</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Mechanism of action of a sulphonylurea receptor SUR1 mutation (F132L) that causes DEND syndrome.</article-title>
                <source>Hum Mol Genet</source>
                <volume>16</volume>
                <fpage>2011</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">17584766</pub-id>
              </element-citation>
            </ref>
            <ref id="dmtn.REF.schwitzgebel.2003.4398">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Schwitzgebel</surname>
                    <given-names>VM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mamin</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brun</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ritz-Laser</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zaiko</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maret</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jornayvaz</surname>
                    <given-names>FR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Theintz</surname>
                    <given-names>GE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Michielin</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Melloul</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Philippe</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Agenesis of human pancreas due to decreased half-life of insulin promoter factor 1.</article-title>
                <source>J Clin Endocrinol Metab</source>
                <volume>88</volume>
                <fpage>4398</fpage>
                <lpage>406</lpage>
                <pub-id pub-id-type="pmid">12970316</pub-id>
              </element-citation>
            </ref>
            <ref id="dmtn.REF.sellick.2004.1301">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sellick</surname>
                    <given-names>GS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barker</surname>
                    <given-names>KT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stolte-Dijkstra</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fleischmann</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coleman</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garrett</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gloyn</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Edghill</surname>
                    <given-names>EL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hattersley</surname>
                    <given-names>AT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wellauer</surname>
                    <given-names>PK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goodwin</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Houlston</surname>
                    <given-names>RS</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Mutations in PTF1A cause pancreatic and cerebellar agenesis.</article-title>
                <source>Nat Genet</source>
                <volume>36</volume>
                <fpage>1301</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">15543146</pub-id>
              </element-citation>
            </ref>
            <ref id="dmtn.REF.sen_e.2006.682">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sen&#x000e9;e</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chelala</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Duchatelet</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Feng</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blanc</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cossec</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Charon</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nicolino</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boileau</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cavener</surname>
                    <given-names>DR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bougn&#x000e8;res</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taha</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Julier</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Mutations in GLIS3 are responsible for a rare syndrome with neonatal diabetes mellitus and congenital hypothyroidism.</article-title>
                <source>Nat Genet</source>
                <volume>38</volume>
                <fpage>682</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">16715098</pub-id>
              </element-citation>
            </ref>
            <ref id="dmtn.REF.shield.1997.f39">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Shield</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gardner</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wadsworth</surname>
                    <given-names>EJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Whiteford</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>James</surname>
                    <given-names>RS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robinson</surname>
                    <given-names>DO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baum</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Temple</surname>
                    <given-names>IK</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Aetiopathology and genetic basis of neonatal diabetes.</article-title>
                <source>Arch Dis Child Fetal Neonatal Ed</source>
                <volume>76</volume>
                <fpage>F39</fpage>
                <lpage>42</lpage>
                <pub-id pub-id-type="pmid">9059185</pub-id>
              </element-citation>
            </ref>
            <ref id="dmtn.REF.shield.2004.f341">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Shield</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Temple</surname>
                    <given-names>IK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sabin</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mackay</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robinson</surname>
                    <given-names>DO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Betts</surname>
                    <given-names>PR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carson</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cave</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chevenne</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Polak</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>An assessment of pancreatic endocrine function and insulin sensitivity in patients with transient neonatal diabetes in remission.</article-title>
                <source>Arch Dis Child Fetal Neonatal Ed</source>
                <volume>89</volume>
                <fpage>F341</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">15210671</pub-id>
              </element-citation>
            </ref>
            <ref id="dmtn.REF.stanik.2007.1276">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Stanik</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gasperikova</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paskova</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barak</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Javorkova</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jancova</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ciljakova</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hlava</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Michalek</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Flanagan</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pearson</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hattersley</surname>
                    <given-names>AT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ellard</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klimes</surname>
                    <given-names>I</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Prevalence of permanent neonatal diabetes in Slovakia and successful replacement of insulin with sulfonylurea therapy in KCNJ11 and ABCC8 mutation carriers.</article-title>
                <source>J Clin Endocrinol Metab</source>
                <volume>92</volume>
                <fpage>1276</fpage>
                <lpage>82</lpage>
                <pub-id pub-id-type="pmid">17213273</pub-id>
              </element-citation>
            </ref>
            <ref id="dmtn.REF.stoffers.1997.106">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Stoffers</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zinkin</surname>
                    <given-names>NT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stanojevic</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clarke</surname>
                    <given-names>WL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Habener</surname>
                    <given-names>JF</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence.</article-title>
                <source>Nat Genet</source>
                <volume>15</volume>
                <fpage>106</fpage>
                <lpage>10</lpage>
                <pub-id pub-id-type="pmid">8988180</pub-id>
              </element-citation>
            </ref>
            <ref id="dmtn.REF.st_y.2008.450">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>St&#x000f8;y</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Greeley</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paz</surname>
                    <given-names>VP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ye</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pastore</surname>
                    <given-names>AN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Skowron</surname>
                    <given-names>KB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lipton</surname>
                    <given-names>RB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cogen</surname>
                    <given-names>FR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bell</surname>
                    <given-names>GI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Philipson</surname>
                    <given-names>LH</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>United States Neonatal Diabetes Working Group. Diagnosis and treatment of neonatal diabetes: a United States experience.</article-title>
                <source>Pediatr Diabetes</source>
                <volume>9</volume>
                <fpage>450</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">18662362</pub-id>
              </element-citation>
            </ref>
            <ref id="dmtn.REF.temple.2000.1359">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Temple</surname>
                    <given-names>IK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gardner</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mackay</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barber</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robinson</surname>
                    <given-names>DO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shield</surname>
                    <given-names>JP</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Transient neonatal diabetes: widening the understanding of the etiopathogenesis of diabetes.</article-title>
                <source>Diabetes</source>
                <volume>49</volume>
                <fpage>1359</fpage>
                <lpage>66</lpage>
                <pub-id pub-id-type="pmid">10923638</pub-id>
              </element-citation>
            </ref>
            <ref id="dmtn.REF.temple.1996.1117">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Temple</surname>
                    <given-names>IK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gardner</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robinson</surname>
                    <given-names>DO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kibirige</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fergusson</surname>
                    <given-names>AW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baum</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barber</surname>
                    <given-names>JCK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>James</surname>
                    <given-names>RS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shield</surname>
                    <given-names>JPH</given-names>
                  </name>
                </person-group>
                <article-title>Further evidence for an imprinted gene for neonatal diabetes localised to chromosome 6q22&#x02013;q23.</article-title>
                <source>Hum Mol Genet.</source>
                <year>1996</year>
                <volume>5</volume>
                <fpage>1117</fpage>
                <lpage>21</lpage>
                <pub-id pub-id-type="pmid">8842729</pub-id>
              </element-citation>
            </ref>
            <ref id="dmtn.REF.valerio.2004.2405">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Valerio</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Franzese</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salerno</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muzzi</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cecere</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Temple</surname>
                    <given-names>KI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shield</surname>
                    <given-names>JP</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Beta-cell dysfunction in classic transient neonatal diabetes is characterized by impaired insulin response to glucose but normal response to glucagon.</article-title>
                <source>Diabetes Care</source>
                <volume>27</volume>
                <fpage>2405</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">15451908</pub-id>
              </element-citation>
            </ref>
            <ref id="dmtn.REF.valleley.2007.972">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Valleley</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cordery</surname>
                    <given-names>SF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonthron</surname>
                    <given-names>DT</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Tissue-specific imprinting of the ZAC/PLAGL1 tumour suppressor gene results from variable utilization of monoallelic and biallelic promoters.</article-title>
                <source>Hum Mol Genet</source>
                <volume>16</volume>
                <fpage>972</fpage>
                <lpage>81</lpage>
                <pub-id pub-id-type="pmid">17341487</pub-id>
              </element-citation>
            </ref>
            <ref id="dmtn.REF.varrault.2001.18653">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Varrault</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bilanges</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mackay</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Basyuk</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ahr</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fernandez</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robinson</surname>
                    <given-names>DO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bockaert</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Journot</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Characterization of the methylation-sensitive promoter of the imprinted ZAC gene supports its role in transient neonatal diabetes mellitus.</article-title>
                <source>J Biol Chem</source>
                <volume>276</volume>
                <fpage>18653</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">11297535</pub-id>
              </element-citation>
            </ref>
            <ref id="dmtn.REF.varrault.2006.711">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Varrault</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gueydan</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Delalbre</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bellmann</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Houssami</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aknin</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Severac</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chotard</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kahli</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Le Digarcher</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pavlidis</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Journot</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Zac1 regulates an imprinted gene network critically involved in the control of embryonic growth.</article-title>
                <source>Dev Cell</source>
                <volume>11</volume>
                <fpage>711</fpage>
                <lpage>22</lpage>
                <pub-id pub-id-type="pmid">17084362</pub-id>
              </element-citation>
            </ref>
            <ref id="dmtn.REF.wiedemann.2010.18">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wiedemann</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schober</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Waldhoer</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koehle</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Flanagan</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mackay</surname>
                    <given-names>DJG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steichen</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meraner</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zimmerhackl</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hattersley</surname>
                    <given-names>AT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ellard</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hofer</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Incidence of neonatal diabetes in Austria &#x02013; Calculation based on the Austrian Diabetes Register.</article-title>
                <source>Pediatr Diabetes</source>
                <volume>11</volume>
                <fpage>18</fpage>
                <lpage>23</lpage>
                <pub-id pub-id-type="pmid">19496964</pub-id>
              </element-citation>
            </ref>
            <ref id="dmtn.REF.yorifuji.2004.2905">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yorifuji</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kurokawa</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mamada</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Imai</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kawai</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishi</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shishido</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hasegawa</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakahata</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Neonatal diabetes mellitus and neonatal polycystic, dysplastic kidneys: Phenotypically discordant recurrence of a mutation in the hepatocyte nuclear factor-1beta gene due to germline mosaicism.</article-title>
                <source>J Clin Endocrinol Metab</source>
                <volume>89</volume>
                <fpage>2905</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">15181075</pub-id>
              </element-citation>
            </ref>
            <ref id="dmtn.REF.yorifuji.1994.331">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yorifuji</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matsumara</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Okuno</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shimizu</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sonomura</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muroi</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuno</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takahashi</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Okuno</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>1994</year>
                <article-title>Hereditary pancreatic hypoplasia, diabetes mellitus, and congenital heart disease: a new syndrome?</article-title>
                <source>J Med Genet</source>
                <volume>31</volume>
                <fpage>331</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">8071961</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="dmtn.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="dmtn.Acknowledgments">
          <title>Acknowledgments</title>
          <p>IKT, LD, and DJGM are supported by Diabetes UK and MRC for work on 6q24 transient neonatal diabetes.</p>
        </sec>
        <sec id="dmtn.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>15 January 2015 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>27 September 2012 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>23 December 2010 (cd) Revision: sequence analysis of <italic toggle="yes">ZFP57</italic> available clinically on a limited basis</p>
            </list-item>
            <list-item>
              <p>4 February 2010 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>10 October 2005 (me) Review posted to live Web site</p>
            </list-item>
            <list-item>
              <p>10 February 2005 (ikt) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
      <sec sec-type="figs-and-tables">
        <title/>
        <fig position="float" id="dmtn.F1" orientation="portrait">
          <label>Figure 1. </label>
          <caption>
            <p>Three different genetic mechanisms cause 6q24-TNDM: paternal UPD (uniparental disomy) of chromosome 6 (41%); duplication of 6q24 on the paternal allele (29%); and expression of the maternal <italic toggle="yes">PLAGL1/HYMAI</italic> differentially methylated region (DMR) due to loss of methylation (hypomethylation) (30%). Maternal <italic toggle="yes">PLAGL1/HYMAI</italic> DMR hypomethylation may result from an isolated imprinting mutation or as part of a more generalized defect termed &#x02018;hypomethylation at imprinted loci&#x02019; (HIL). Homozygous or compound heterozygous <italic toggle="yes">ZFP57</italic> mutations account for almost half of TNDM-HIL; the other causes of HIL are not known.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="dmtn-Image001" position="anchor" orientation="portrait"/>
        </fig>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
